reference/17434846

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17434846

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	258
issn	0161-5505 2159-662X
issueIdentifier	2
pageRange	252-258
publicationName	Journal of nuclear medicine : official publication, Society of Nuclear Medicine
startingPage	252
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5644ac74d485a2a0d8cb672bfb7166b0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_37a02e6ef915117125f104718af681cc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e1ffbaf76717296def52d270b1856f67 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d1a1784e7a6402c9ce78d46b5646e385 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5299b214549e37726913f342090d6e58 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7364311c284ec2633bcb3473cf02bcf1
bibliographicCitation	Habibollahi P, van den Berg NS, Kuruppu D, Loda M, Mahmood U. Metformin—an Adjunct Antineoplastic Therapy—Divergently Modulates Tumor Metabolism and Proliferation, Interfering with Early Response Prediction by ¹⁸F-FDG PET Imaging. J Nucl Med. 2013 Feb;54(2):252–8. doi: 10.2967/jnumed.112.107011.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd952f21aa8a60bdabba8e2c29884b31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a68ed34d7a7017c7100436ae8fa87ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edc91a75fc52ec858d1500f3e299872e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3088dac1a696393e5241fffc765b9b9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c732930bdaac042faebed3aad3b32f82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7414-6123
date	201302
identifier	https://doi.org/10.2967/jnumed.112.107011 https://pubmed.ncbi.nlm.nih.gov/PMC3703242 https://pubmed.ncbi.nlm.nih.gov/23376854
isPartOf	https://portal.issn.org/resource/ISSN/0161-5505 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5045 https://portal.issn.org/resource/ISSN/2159-662X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Metformin—an Adjunct Antineoplastic Therapy—Divergently Modulates Tumor Metabolism and Proliferation, Interfering with Early Response Prediction by 18F-FDG PET Imaging
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0517349 http://id.nlm.nih.gov/mesh/M0029360 http://id.nlm.nih.gov/mesh/M0013535
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D008687Q000494 http://id.nlm.nih.gov/mesh/D019788Q000494 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D049268Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002453 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D017209 http://id.nlm.nih.gov/mesh/D008954 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D055372Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018572
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.13.3 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22596859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87169185 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf22a1d0acfca4af517e1417a80e92d1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577443 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a81b4e81fe71a07613c76a5538fe8b5e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 69.